Viatris Inc (VTRS) Stock Price & Analysis
Viatris Inc (VTRS) fell 0.35% to USD 16.88 as of September 8, 2026 at 03:34 UTC, according to Nexqual real-time market data.
VTRS last closed at USD 16.88; the session ranged USD 16.67–17.02 on volume of 5,732,791 shares. Market capitalization is —, with a 52-week range of USD 9.43–18.39 (NMS). Source: Nexqual, September 8, 2026 at 03:34 UTC.
Key Statistics (as of September 8, 2026 at 03:34 UTC)
| Price | USD 16.88 |
|---|---|
| Change | ▼ 0.35% (down) |
| Previous Close | USD 16.88 |
| Open | USD 16.88 |
| Day Range | USD 16.67 – 17.02 |
| 52-Week Range | USD 9.43 – 18.39 |
| Volume | 5,732,791 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (VTRS)
Nexqual's technical model rates VTRS "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 03:34 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 51.38 (neutral) |
| vs SMA50 | Above (USD 16.76) |
| MACD | 0.03 (positive) |
From Viatris Inc's Latest SEC 10-K Filing (filed 2026-02-26)
Key Strengths & Strategy (as disclosed to the SEC)
- Viatris retained some selective R&D capabilities in API. • In July 2024, the Company completed the divestiture of its OTC Business to Cooper Consumer Health, a leading European OTC drug manufacturer and distributor.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OGN | Organon & Co. | USD 13.78 | ▲ 0.07% |
| WBD | Warner Bros. Discovery, Inc. - | USD 28.25 | ▼ 0.49% |
| CTVA | Corteva, Inc. | USD 87.86 | ▼ 2.35% |
| GEHC | GE HealthCare Technologies Inc. | USD 68.86 | ▼ 2.41% |
| LUMN | Lumen Technologies, Inc. | USD 6.77 | ▼ 0.59% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 03:34 UTC. This page is informational and not investment advice.